Private practices face a number of challenges—especially those offering innovative treatments like TMS or ketamine. We explore the largest time and financial costs clinicians face and propose three solutions to reduce the burden.
View older posts
A step-by-step checklist for establishing your private psychiatry practice, including: Naming your company, determining your business type and incorporation, applying for an EIN and Type II NPI, opening a business account and credit card, getting a system for keeping your books, updating your contact information, and DEA.
Depression and mental health issues are a leading cause of disability in the world according to the WHO. Despite the desperate need, innovative mental health treatments have stalled for the last 50 years due to financial, regulatory, and administrative barriers to implementation and access. In pt. 1 of this 3-part series, we explore the costs of ketamine treatments and plot a path forward to expand access to life-saving treatments.
2022 has been a landmark year for psychedelic regulatory easing. As we head into 2023, stay up to date at the federal, state, and city levels. Legal resources for clinicians are provided.
Mike leads his team to solve hard problems in healthcare to make the patient journey easier, care more affordable, and drive better outcomes. Learn about his journey from an EMT on the frontlines to using data to bring forward the future of mental health care.
A practical framework for answering "who" you work with and "how"—set this foundation before you advertise your services.
A practical checklist and downloadable template to plan the budget for your psychiatry private practice
Before you spend any money on starting your private psychiatry practice, write out your answers to these 4 questions to guide you.
Automate parts of your charting with a library of 60+ psychiatry smart phrases/text-snippets.
A checklist of what you need to include in your initial psychiatric eval and how to streamline the process
Explore the research, patient experiences and preferences, and efficacy of music and psychedelic-assisted therapies—namely ketamine.
It’s been a big year for ketamine infusion therapy (KIT), with an abundance of real-world evidence (RWE) publications supporting the efficacy of KIT for depression, suicide and now anxiety. We explore conclusions from the literature and further questions for research.
As part of our “Employee Spotlight” series, we welcome Product Manager, Dan Snyder to share highlights of his first 6 months of working at Osmind.
Mental health clinicians treating patients with moderate to severe mental health conditions face increased demands on their time.
You need to accept credit cards in your practice, but not all processors are created equally. Here are 10 questions to ask when evaluating potential credit card processors for your practice and how they will work with your EHR and practice management systems.
We made major improvements to help you focus on your patients and your clinic—from templates to save you time, simplified payments, intake improvements, and a practice community of supportive peers.
HR Director Quinn M. rode her bike 545 miles from SF to LA with AIDS/LifeCycle to raise money for HIV/AIDS awareness. Here's her mission-driven journey:
A practical guide to screening and intake for new potential patients in your private psychiatry practice.
Clinicians need to have a realistic picture of sublingual (SL) ketamine troches for home use. This guide covers the efficacy, concerns, and clinical guidelines for getting started with ketamine troches.
Hear how Ami Miller of Scenic City Neurotherapy keeps patients engaged and her team organized with Osmind.
As part of our “Employee Spotlight: New Hire” series, we welcome Moises Daniel, Software Engineer to share highlights of his first 3 months of working at Osmind.
Dr. L. Alison McInnes provides an introduction to sublingual ketamine troches for home use through the lens of evidence-based medicine
Dr. Carlene MacMillan shares four foundational steps for psychiatrists interested in opening their own private practice
Dr. L. Alison McInnes discusses ways for busy clinicians to empower ketamine infusion therapy patients with measurement-based care
Pragmatic ways that clinicians can implement measurement-based care into their ketamine practices to positively affect patient engagement and retention.
When it comes to mental health care, especially the care of more chronic or complex conditions, many patients work with a multidisciplinary team of helpers.
Dr. Alison McInnes discusses how clinicians can implement measurement-based care into their practices to build a stronger therapeutic alliance with treatment-resistant depression patients and improve their outcomes
Dr. Carlene MacMillan shares tips for working with insurance and addressing coverage with patients in your mental health practice.
Dr. McInnes discusses whether clinicians who provide PAT should have a personal experience with the treatment before administering it to their patients.
Osmind introduces its first Public Benefit Corporation Report, which includes details about the company’s activities and progress toward advancing mental health interventions.
Lucia Huang, co-founder, and CEO of Osmind, discusses the company’s Series B funding and ongoing commitment to responsible innovation and research toward new mental health treatments.
Jimmy Qian, co-founder and COO of Osmind, introduces the new Osmind logo and brand.
The Ketamine and Related Compounds International Hybrid Conference held in Oxford was attended by many academics who made landmark discoveries in the rapid-acting antidepressant (RAAD) space. Dr. Alison McInnes shares the main takeaways from the conference.
Carlene MacMillan, VP of Clinical Innovation at Osmind, guides you through the new DSM-5-TR, and outlines the changes that stand out.
It’s critical for your clinical practice to stay current with the newest research literature, but it can be hard to keep up. The Evidence Base aims to help clinicians follow the developments that advance evidence-based mental health practices.
If you recently added Spravato® treatment to your practice services, it’s likely your qualified patients will have important questions before they begin treatment sessions.
If you’re starting up a clinic or adding interventional mental health services to your practice, including ketamine therapy, SPRAVATO(R), psychedelic medicine, or neuromodulation such as TMS, an EHR that can handle specialized treatments and workflows will save you time and help you deliver a better patient experience.
Several recent key studies show promising evidence that support digital device use and passive sensing in the treatment of depression. Almost everything we do now in modern life generates data - and we can learn from it.
Make it easy to see appointments and events across your practice by connecting your Osmind EHR with your Google Calendars. Osmind practices can now easily sync appointments and events between a clinician’s Google Calendar and the Osmind EHR, directly from the Schedule tab within Osmind.
If you’re starting a new practice that offers innovative treatments such as ketamine infusions and TMS, you’ll need to ask critical questions before selecting your malpractice insurance carrier and coverage.
Over a year ago, when things were really bad in his life, Sean tried ketamine therapy. Ketamine is a legal anesthetic that is approved by the FDA.
We’re excited to announce our partnership with the American Association for Precision Medicine (AAPM)!
On September 30, 2020, the Osmind team hosted an AMA (“Ask Me Anything”) on the Osmind forum with Paul Austin.
“At one point or another, each and every one of us will benefit from the care and protection provided by our emergency services.”- Prince William
We’re excited to announce today that MoodMonitor is merging into Osmind.
On Thursday, July 30th, 2020, we hosted a video AMA on the Osmind community with Andrew Penn
The field of psychedelics has seen an explosion of new organizations and interests. At Osmind, we’re building the digital infrastructure that’s